Skip to main content

Surgical Intervention for Skin Cancer in Organ Transplant Recipients

  • Chapter
Book cover Skin Cancer after Organ Transplantation

Part of the book series: Cancer Treatment and Research ((CTAR,volume 146))

  • 1178 Accesses

An important complication of solid organ transplantation and chemical immunosuppression is the potential for the development of multiple skin cancers, especially squamous cell carcinomas [1]. The magnitude and severity of these malignancies are troublesome. They are often multiple, are associated with verrucal lesions, are more likely to occur at a younger age, and have a higher recurrence rate than in those who do not receive transplants, are capable of rapid growth, have an aggressive histological growth pattern [2,3], and are prone to metastasis on the trunk and extremities as well as the head and neck.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Randle HW. The historical link between solid-organ transplantation, immunosuppression, and skin cancer. Dermatol Surg 2004; 30(4 pt 2):595–7.

    Article  PubMed  Google Scholar 

  2. Harwood CA, Proby CM, McGregor JM, Sheaff MT, Leigh IM, Cerio R. Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J Am Acad Dermatol 2006; 54:290–300.

    Article  PubMed  Google Scholar 

  3. Smith KJ, Hamza S, Skelton H. Histologic features in primary cutaneous squamous cell carcinomas in immunocompromised patients focusing on organ transplant patients. Dermatol Surg 2004; 30(4 pt 2):634–41.

    Article  PubMed  Google Scholar 

  4. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348:1681–91.

    Article  PubMed  Google Scholar 

  5. Bouwes Bavinck JN, Hardie DR, Green A, Cutmore S, MacNaught A, O’Sullivan B, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia: a follow-up study. Transplantation 1996; 61:715–21.

    Article  PubMed  CAS  Google Scholar 

  6. Shelley WB, Shelley ED. Advanced dermatologic therapy. Philadelphia: Saunders, 1987.

    Google Scholar 

  7. Demetrius RW, Randle HW. High-risk nonmelanoma skin cancers. Dermatol Surg 1998; 24:1272–92.

    Article  PubMed  CAS  Google Scholar 

  8. Euvrard S, Kanitakis J, Claudy A. Neoplastic skin diseases in organ transplant recipients. Am J Cancer 2002; 1:109–20.

    Article  Google Scholar 

  9. Stasko T, Brown MD, Carucci JA, Euvrard S, Johnson TM, Sengelmann RD, et al.; International Transplant-Skin Cancer Collaborative; European Skin Care in Organ Transplant Patients Network. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg 2004; 30(4 pt 2):642–50.

    Article  PubMed  Google Scholar 

  10. Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47:1–17.

    Article  PubMed  Google Scholar 

  11. Martinez JC, Otley CC. Megasession: excision of numerous skin cancers in a single session. Dermatol Surg 2005; 31(7 pt 1):757–61.

    PubMed  CAS  Google Scholar 

  12. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection. J Am Acad Dermatol 1992; 26:976–90.

    Article  PubMed  CAS  Google Scholar 

  13. Carucci JA, Martinez JC, Zeitouni NC, Christenson L, Coldiron B, Zweibel S, et al. In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management, and outcome in a series of 21 patients. Dermatol Surg 2004; 30 (4 pt 2):651–5.

    Article  PubMed  Google Scholar 

  14. van Zuuren EJ, Posma AN, Scholtens RE, Vermeer BJ, van der Woude FJ, Bouwes Bavinck JN. Resurfacing the back of the hand as treatment and prevention of multiple skin cancers in kidney transplant recipients. J Am Acad Dermatol 1994; 31 (5 pt 1):760–4.

    PubMed  Google Scholar 

  15. Marks R. Skin cancer in organ transplant patients: from a side effect of social practice to a side effect of medical practice. Dermatol Surg 2004; 30 (4 pt 2):593–4.

    Article  PubMed  Google Scholar 

  16. McNamara D. Advised transplant patients of higher skin cancer risk. Skin Allergy News 2005; 36:33.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Randle, H.W. (2009). Surgical Intervention for Skin Cancer in Organ Transplant Recipients. In: Stockfleth, E., Ulrich, C. (eds) Skin Cancer after Organ Transplantation. Cancer Treatment and Research, vol 146. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-78574-5_35

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-78574-5_35

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-78573-8

  • Online ISBN: 978-0-387-78574-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics